Sanofi (SNY)

49.39 +0.36 (0.73%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/8/21 *Est.)
- M&A (12/31/20 *Est)

Latest Headlines

Deutsche Bank Starts Sanofi (SAN:FP) (SNY) at Sell January 15, 2021 5:32 AM - StreetInsider Form 6-K Sanofi For: Jan 12 January 12, 2021 2:58 PM - SEC Filing SANOFI unveils EUROAPI as the name of the new industry leading European API* company and appoints Karl Rotthier as its future Chief Executive Officer January 12, 2021 8:30 AM - Globe NewsWire Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor January 12, 2021 8:00 AM - PR NewsWire Moderna (MRNA) Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines January 11, 2021 7:21 AM - StreetInsider Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines January 11, 2021 7:20 AM - BizWire Sanofi (SNY) Reports Acquisition of Kymab, Adding KY1005 to Pipeline January 11, 2021 5:44 AM - StreetInsider Sanofi buys Kymab for up to $1.5 billion to expand in immunotherapy January 11, 2021 4:05 AM - StreetInsider Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L January 11, 2021 2:30 AM - Globe NewsWire Sanofi (SAN:FP) (SNY) PT Lowered to EUR101 at Morgan Stanley January 8, 2021 2:06 AM - StreetInsider Arthritis Drugs Reduce Covid-19 Deaths, ICU Time in Study - Bloomberg January 7, 2021 11:02 AM - StreetInsider Corinne Le Goff, Pharm.D. Will Join Moderna as Chief Commercial Officer on January 19 January 7, 2021 8:00 AM - BizWire Bernstein Reiterates Outperform Rating on Sanofi (SAN:FP) (SNY) January 4, 2021 4:05 PM - StreetInsider Drugmakers including Pfizer (PFE), Sanofi (SNY), GlaxoSmithKline (GSK) plan to raise U.S. prices on more than 300 drugs on Jan 1 - Reuters December 31, 2020 2:56 PM - StreetInsider Sanofi's vaccine will start Phase 2B program in the middle of February - Slaoui December 30, 2020 12:12 PM - StreetInsider Form 6-K Sanofi For: Dec 18 December 18, 2020 2:14 PM - SEC Filing Mylan (VRTS) Wins Summary Judgment in EpiPen Litigation Brought by Sanofi (SNY) December 18, 2020 12:22 PM - StreetInsider Sanofi (SNY) March 50 calls active December 16, 2020 4:36 AM - StreetInsider Form 6-K Sanofi For: Dec 11 December 11, 2020 3:26 PM - SEC Filing Sanofi (SNY) Announces CHMP recommends approval of Plavix with aspirin in adults for certain types of strokes December 11, 2020 8:33 AM - StreetInsider CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes December 11, 2020 8:30 AM - Globe NewsWire Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly December 11, 2020 1:00 AM - Globe NewsWire Sanofi (SNY) option implied volatility flat at 28 December 10, 2020 10:03 AM - StreetInsider Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities December 9, 2020 1:00 AM - Globe NewsWire Form 6-K Sanofi For: Dec 03 December 3, 2020 1:41 PM - SEC Filing Increasing unusual call option volume: SNDL CX QEP GMHI BB SNY EQX ARLO December 2, 2020 11:44 AM - StreetInsider Citi Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) December 1, 2020 4:39 AM - StreetInsider Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis November 30, 2020 1:00 AM - Globe NewsWire Form 6-K Sanofi For: Nov 25 November 25, 2020 12:40 PM - SEC Filing Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib November 24, 2020 8:03 AM - StreetInsider AstraZeneca (AZN) Tried to Embellish Vaccine Data, SVB Leerink Says November 23, 2020 8:46 AM - StreetInsider European Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older November 23, 2020 4:00 AM - Globe NewsWire Form 6-K Sanofi For: Nov 19 November 19, 2020 1:28 PM - SEC Filing UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) November 19, 2020 4:40 AM - StreetInsider European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older November 18, 2020 1:12 PM - Globe NewsWire Sanofi (SNY) announces FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease November 18, 2020 6:16 AM - StreetInsider Sanofi (SNY) announces Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia November 18, 2020 6:14 AM - StreetInsider Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia November 18, 2020 1:15 AM - Globe NewsWire FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease November 18, 2020 1:00 AM - Globe NewsWire FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease November 13, 2020 7:00 PM - Globe NewsWire Americans Getting More Comfortable with COVID-19 Vaccine but Compliance Still Unclear November 12, 2020 9:37 AM - StreetInsider Exane BNP Paribas Reinstates Sanofi (SAN:FP) (SNY) at Outperform November 12, 2020 8:59 AM - StreetInsider UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) November 11, 2020 3:52 PM - StreetInsider Berenberg Reiterates Hold Rating on Sanofi (SAN:FP) (SNY) November 10, 2020 8:01 AM - StreetInsider Form 6-K Sanofi For: Nov 04 November 4, 2020 3:28 PM - SEC Filing Sanofi (SAN:FP) (SNY) PT Lowered to EUR105 at Morgan Stanley November 3, 2020 4:35 AM - StreetInsider Regulus Therapeutics (RGLS) Reports Achievement of Interim Enrollment Milestone Under Collaboration with Sanofi (SNY) November 2, 2020 8:12 AM - StreetInsider Sanofi (SNY) Reports Acquisition of Kiadis for EUR308M November 2, 2020 5:54 AM - StreetInsider Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products November 2, 2020 1:15 AM - Globe NewsWire Credit Suisse Reiterates Outperform Rating on Sanofi (SAN:FP) (SNY) November 1, 2020 2:36 PM - StreetInsider UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) November 1, 2020 2:09 PM - StreetInsider Form 6-K Sanofi For: Oct 30 October 30, 2020 5:10 PM - SEC Filing Sanofi (SAN:FP) (SNY) PT Lowered to EUR100 at JPMorgan October 30, 2020 6:43 AM - StreetInsider Form 6-K Sanofi For: Sep 30 October 29, 2020 10:23 AM - SEC Filing European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab) October 29, 2020 9:50 AM - Globe NewsWire Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER October 29, 2020 2:30 AM - Globe NewsWire Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA® (pembrolizumab) in pursuit of establishing a new treatment option in oncology October 29, 2020 2:00 AM - Globe NewsWire Fauci Says Vaccine Won't Be Available Until Jan. at Earliest - Bloomberg, Citing Comments at JAMA October 28, 2020 3:52 PM - StreetInsider Sanofi (SNY) and GSK (GSK) to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine October 28, 2020 6:54 AM - StreetInsider Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine October 28, 2020 2:00 AM - Globe NewsWire Form 6-K Sanofi For: Oct 27 October 27, 2020 1:04 PM - SEC Filing UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) October 26, 2020 3:45 PM - StreetInsider Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings October 26, 2020 8:00 AM - Globe NewsWire Sanofi and the Parkinson's Foundation collaborate to advance the availability of free genetic testing and counseling for people with Parkinson's disease October 21, 2020 7:00 AM - PR NewsWire Full Article List